newsfilter
← Latest News
PR Newswire·

BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting

New analysis showcases impact of VOXZOGO® (vosoritide) in foramen magnum and craniocervical junction growth in children with achondroplasia, including infantsSAN RAFAEL, Calif., Oct. 9, 2026 /PRNewswire/ -- BioMarin